{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-24-000032","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.253215+00:00","generated_at":"2026-05-30T22:54:43.967759+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ICU Medical appoints Daniel Woolson as President, effective Sept. 30, 2024","bullets":["Daniel Woolson, 48, appointed President of ICU Medical, effective immediately on Sept. 30, 2024.","Woolson previously served as Corporate VP and General Manager - Infusion Systems since 2017.","Prior roles include President, Respiratory Solutions at Becton Dickinson (2015-2016) and VP/GM at CareFusion.","No departure of current CEO or other officers was announced in connection with this appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-24-000032","json":"https://secwatch.observer/filing/0000883984-24-000032.json","markdown":"https://secwatch.observer/filing/0000883984-24-000032.md","text":"https://secwatch.observer/filing/0000883984-24-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/0000883984-24-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/icui-20240930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T22:54:43.967759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1b8fa9a92","claim":"Daniel Woolson was appointed as President at ICU MEDICAL INC/DE.","evidence_excerpt":"On September 30, 2024, the Board of Directors of ICU Medical, Inc. (the “Company”) appointed Mr. Daniel Woolson, 48, as President of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/0000883984-24-000032-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}